Trial Profile
A Phase I, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine Administrated With Adjuvant AlPO4 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Enterovirus A vaccine (Primary) ; Alum
- Indications Enterovirus A infections
- Focus Adverse reactions
- 06 Jan 2011 New trial record